Synovus Financial’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,442
Closed -$453K 960
2025
Q2
$453K Sell
1,442
-1,207
-46% -$362K 0.01% 691
2025
Q1
$807K Buy
2,649
+1,148
+76% +$386K 0.01% 527
2024
Q4
$499K Sell
1,501
-209
-12% -$70.9K 0.01% 643
2024
Q3
$571K Sell
1,710
-257
-13% -$97.6K 0.01% 650
2024
Q2
$810K Sell
1,967
-174
-8% -$68.9K 0.01% 496
2024
Q1
$865K Sell
2,141
-33
-2% -$11.6K 0.01% 489
2023
Q4
$666K Buy
2,174
+493
+29% +$133K 0.01% 527
2023
Q3
$407K Buy
1,681
+326
+24% +$83.4K ﹤0.01% 664
2023
Q2
$325K Sell
1,355
-90
-6% -$18.7K ﹤0.01% 708
2023
Q1
$272K Sell
1,445
-550
-28% -$114K ﹤0.01% 739
2022
Q4
$424K Buy
1,995
+28
+1% +$5.59K ﹤0.01% 650
2022
Q3
$306K Sell
1,967
-1,435
-42% -$229K ﹤0.01% 703
2022
Q2
$502K Sell
3,402
-682
-17% -$98.7K 0.01% 586
2022
Q1
$660K Buy
4,084
+1,492
+58% +$246K 0.01% 540
2021
Q4
$569K Sell
2,592
-469
-15% -$98.2K 0.01% 604
2021
Q3
$587K Buy
3,061
+101
+3% +$18.4K 0.01% 569
2021
Q2
$530K Buy
2,960
+20
+0.7% +$3.45K 0.01% 598
2021
Q1
$475K Buy
+2,940
New +$450K 0.01% 563
2020
Q2
Sell
-123
Closed -$9K 1902
2020
Q1
$9K Buy
+123
New +$10.7K ﹤0.01% 1601

Other funds holding MEDP

Synovus Financial's MEDP Position: Q3 2025 in Review

Synovus Financial sold out of Medpace (MEDP) in Q3 2025, closing a stake of 1,442 shares — an estimated $453K sold.

Synovus Financial first reported a position in MEDP in Q1 2020 and held it in 19 quarters. The position peaked at $865K in Q1 2024. 672 funds tracked by Wall St. Rank hold MEDP as of Q3 2025.

  • Synovus Financial reported no remaining Medpace position as of Q3 2025 after selling out during the quarter.
  • Synovus Financial sold 1,442 Medpace shares in Q3 2025, an estimated $453K.
  • Synovus Financial first reported a position in Medpace in Q1 2020 and held it in 19 quarters.
  • Synovus Financial's Medpace position peaked at $865K in Q1 2024.
  • 672 funds tracked by Wall St. Rank held Medpace as of Q3 2025.

Based on Synovus Financial's 13F filing for Q3 2025, filed 7 Nov 2025.